BMJ  2007;335:432 (1 September), doi:10.1136/bmj.39269.672188.AE (published 19 August 2007)

Research

Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study

¹ Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 900 Commonwealth Avenue, Boston, MA 02215, USA, ² Divisions of Preventive Medicine and Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital

Objective To compare cardiovascular risk among women with high normal blood pressure (130-9/85-9 mm Hg) against those with normal blood pressure (120-9/75-84 mm Hg) and those with baseline hypertension.

Design Prospective cohort study.

Setting Women's health study, United States.

Participants 39 322 initially healthy women classified into four categories according to self reported baseline blood pressure and followed for a median of 10.2 years.

Main outcome measures Time to cardiovascular death, myocardial infarction, or stroke (major cardiovascular event—primary end point); progression to hypertension.

Results 982 (2.5%) women developed a major cardiovascular event, and 8686 (30.1%) women without baseline hypertension progressed to hypertension. The age adjusted event rate for the primary end point was 1.6/1000 person years among women with normal blood pressure, 2.9/1000 person years among those with high normal blood pressure, and 4.3/1000 person years among those with baseline hypertension. Compared with women with high normal blood pressure (reference group), those with normal blood pressure had a lower risk of a major cardiovascular event (adjusted hazard ratio 0.61, 95% confidence interval 0.48 to 0.76) and of incident hypertension (0.42, 0.40 to 0.44). The hazard ratio for a major cardiovascular event in women with baseline hypertension was 1.30 (1.08 to 1.57). Women who progressed to hypertension (reference group) during the first 48 months of the study had a higher cardiovascular risk than those who remained normotensive (adjusted hazard ratio 0.64, 0.50 to 0.81). Women with high normal blood pressure at baseline who progressed to hypertension (reference group) had similar outcome rates to women with baseline hypertension (adjusted hazard ratio 1.17, 0.88 to 1.55).

Conclusion The cardiovascular risk of women with high normal blood pressure is higher than that of women with normal blood pressure. The cardiovascular risk of women who progress to hypertension is increased shortly after a diagnosis of hypertension has been made.

Trial registration Clinical trials NCT00000479 [ClinicalTrials.gov] .

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Reassessing normal blood pressure

Ira S Nash
BMJ 2007 335: 408-409. [Extract] [Full Text] [PDF]

Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)

Nancy R Cook, Jeffrey A Cutler, Eva Obarzanek, Julie E Buring, Kathryn M Rexrode, Shiriki K Kumanyika, Lawrence J Appel, and Paul K Whelton
BMJ 2007 334: 885. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Conen, D., Glynn, R. J., Ridker, P. M., Buring, J. E., Albert, M. A. (2009). Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals. Eur Heart J 30: 1378-1384 [Abstract] [Full text]  
• Conen, D., Tedrow, U. B., Koplan, B. A., Glynn, R. J., Buring, J. E., Albert, C. M. (2009). Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women. Circulation 119: 2146-2152 [Abstract] [Full text]  
• Rohatagi, S., Lee, J., Shenouda, M., Haworth, S., Bathala, M. S., Allison, M., Rubets, I., Heyrman, R., Noveck, R., Salazar, D. E. (2008). Pharmacokinetics of Amlodipine and Olmesartan After Administration of Amlodipine Besylate and Olmesartan Medoxomil in Separate Dosage Forms and as a Fixed-Dose Combination. J Clin Pharmacol 48: 1309-1322 [Abstract] [Full text]  
• Pletcher, M. J., Bibbins-Domingo, K., Lewis, C. E., Wei, G. S., Sidney, S., Carr, J. J., Vittinghoff, E., McCulloch, C. E., Hulley, S. B. (2008). Prehypertension during Young Adulthood and Coronary Calcium Later in Life. ANN INTERN MED 149: 91-99 [Abstract] [Full text]  
• Coylewright, M., Reckelhoff, J. F., Ouyang, P. (2008). Menopause and Hypertension: An Age-Old Debate. Hypertension 51: 952-959 [Full text]  
• Conen, D., Ridker, P. M., Mora, S., Buring, J. E., Glynn, R. J. (2007). Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study. Eur Heart J 28: 2937-2943 [Abstract] [Full text]  
• Nilsson, P. M. (2007). High-normal blood pressure and future risks a new concern for clinicians?. Eur Heart J 28: 2832-2833 [Full text]  
• Conen, D., Glynn, R. J., Buring, J. E., Ridker, P. M, Zee, R. Y.L. (2007). Natriuretic Peptide Precursor A Gene Polymorphisms and Risk of Blood Pressure Progression and Incident Hypertension. Hypertension 50: 1114-1119 [Abstract] [Full text]  
• (2007). Even High-Normal Blood Pressure Carries CV Risk. JWatch Women's Health 2007: 4-4 [Full text]  
• (2007). High-Normal Blood Pressure Is Associated with Cardiovascular Risk in Women. JWatch Emergency Med. 2007: 3-3 [Full text]  
• Nash, I. S (2007). Reassessing normal blood pressure. BMJ 335: 408-409 [Full text]  

Online poll

Find out more >>